Przejdź do zawartości
Merck

Echinacea purpurea root extract enhances the adipocyte differentiation of 3T3-L1 cells.

Archives of pharmacal research (2013-10-03)
Dong-Mi Shin, Kyeong-Mi Choi, Youn-Sun Lee, Wonkyun Kim, Kyong-Oh Shin, Seikwan Oh, Jae-Chul Jung, Mi Kyeong Lee, Yong-Moon Lee, Jin Tae Hong, Yeo-Pyo Yun, Hwan-Soo Yoo
ABSTRAKT

Echinacea purpurea has been shown to have anti-diabetic activities; for example, it activates peroxisome proliferator-activated receptor γ (PPARγ) and increases insulin-stimulated glucose uptake. Adipogenesis has been used to study the insulin signaling pathway and to screen anti-diabetic compounds. The present study was conducted to investigate the effects of an ethanol extract of E. purpurea (EEEP) and its constituents on the insulin-induced adipocyte differentiation of 3T3-L1 preadipocytes. When adipocyte differentiation was induced with insulin plus 3-isobutyl-1-methylxanthine and dexamethasone, the accumulation of lipid droplets and the cellular triglyceride content were significantly increased by EEEP. The expressions of PPARγ and C/EBPα in adipocytes treated with EEEP were gradually increased as compared with control cells. Fat accumulation and triglyceride content of adipocytes treated with dodeca-2(E),4(E)-dienoic acid isobutylamide were significantly increased as compared with control cells. The expressions of PPARγ and C/EBPα in adipocytes treated with dodeca-2(E),4(E)-dienoic acid isobutylamide were significantly higher than in control cells. These results suggest EEEP promotes the adipogenesis that is partially induced by insulin and that dodeca-2(E),4(E)-dienoic acid isobutylamide appears to be responsible for EEEP-enhanced adipocyte differentiation.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Chlorogenic acid, European Pharmacopoeia (EP) Reference Standard
Chlorogenic acid, primary reference standard
Sigma-Aldrich
Troglitazone, ≥98% (HPLC)
Sigma-Aldrich
3-Isobutyl-1-methylxanthine, BioUltra, ≥99%
Sigma-Aldrich
3-Isobutyl-1-methylxanthine, ≥99% (HPLC), powder
Sigma-Aldrich
Chlorogenic acid, ≥95% (titration)
Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Echinacoside, 98% (HPLC)
Sigma-Aldrich
Dexamethasone, ≥98% (HPLC), powder
Sigma-Aldrich
Dexamethasone, powder, γ-irradiated, BioXtra, suitable for cell culture, ≥80% (HPLC)
Sigma-Aldrich
Dexamethasone, meets USP testing specifications
Sigma-Aldrich
Dexamethasone, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
Caffeic acid, ≥98.0% (HPLC)
Sigma-Aldrich
Dexamethasone, tested according to Ph. Eur.
Supelco
Caffeic acid, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)
Supelco
Dexamethasone, VETRANAL®, analytical standard
Dexamethasone, European Pharmacopoeia (EP) Reference Standard
Supelco
Echinacoside, analytical standard
Dexamethasone, British Pharmacopoeia (BP) Assay Standard
USP
Dexamethasone, United States Pharmacopeia (USP) Reference Standard
Supelco
Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material
Dexamethasone for system suitability, European Pharmacopoeia (EP) Reference Standard